ResMed Inc. Free Cash Flow 2009–2025
ResMed Inc. reported $1.66B of free cash flow for fiscal 2025. That was 27.6% higher than fiscal 2024. Compared with fiscal 2020, the change was +135.1%.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $1.66B | +27.6% |
| FY 2024 | $1.30B | +126.9% |
| FY 2023 | $573.63M | +165.2% |
| FY 2022 | $216.31M | -65.9% |
| FY 2021 | $634.01M | -10.3% |
| FY 2020 | $706.92M | +81.1% |
| FY 2019 | $390.34M | -11.8% |
| FY 2018 | $442.44M | +25.8% |
| FY 2017 | $351.83M | -28.1% |
| FY 2016 | $489.40M | +52.6% |
| FY 2015 | $320.68M | +0.7% |
| FY 2014 | $318.55M | -6.1% |
| FY 2013 | $339.24M | +1.0% |
| FY 2012 | $336.02M | +55.1% |
| FY 2011 | $216.58M | +64.9% |
| FY 2010 | $131.36M | +1.7% |
| FY 2009 | $129.19M | — |
Source: ResMed Inc. SEC filings — cash flow statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open RMD 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
ResMed Inc. reported $1.66B of free cash flow for fiscal 2025. That was 27.6% higher than fiscal 2024. Compared with fiscal 2020, the change was +135.1%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for ResMed Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeResMed Inc. — frequently asked questions
What is ResMed Inc.'s free cash flow?
ResMed Inc. (RMD) reported free cash flow of $1.66B for fiscal year 2025, per its SEC filings.
How has ResMed Inc.'s free cash flow changed over time?
Between fiscal 2009 and 2025, RMD's free cash flow grew at roughly 17.3% per year (compound annual rate), from $129.19M to $1.66B.
Where does this data come from?
Figures are computed from ResMed Inc.'s official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.